All In Biotech

Drug Trial Radar · NCT04688736

Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.

A Prospective, Randomized, Double-blind Controlled Trial of Chlorpheniramine Pretransfusion Medication for Allergic Transfusion Reactions

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 6,642 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

6,642

Planned (sponsor's estimate)

Start

Jan 1, 2021

Primary completion

Dec 31, 2026

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Institute of Hematology & Blood Diseases Hospital, ChinaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, randomized, double-blind controlled trial to evaluate the efficacy of placebo versus chlorpheniramine for the prevention of allergic transfusion reactions.

Conditions

  • Allergic Transfusion Reaction

Interventions

  • PlaceboDrug

    The tablet resembles chlorpheniramine but has no therapeutic value.

  • ChlorpheniramineDrug

    An antihistamine that reduces the natural chemical histamine in the body.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The rate of allergic-transfusion reactionsTime frame: within 4 hours from the start of the transfusion

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Not yet recruiting

  • Zhoukou Central Hospital

    Zhoukou, Henan, China · Recruiting

  • The Second Affilated Hospital of Shandong First Medical University

    Tai’an, Shandong, China · Recruiting

  • Regenerative Medicine Center

    Tianjin, Tianjin Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.